trending Market Intelligence /marketintelligence/en/news-insights/trending/2OyKMvrF364YYvVlOHGP7w2 content esgSubNav
In This List

Haba Laboratories fiscal Q3 profit falls YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix


Haba Laboratories fiscal Q3 profit falls YOY

Haba Laboratories Inc. said its normalized net income for the fiscal third quarter ended Dec. 31, 2014, amounted to ¥15.73 per share, a decrease of 84.7% from ¥103.11 per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥61.9 million, a decrease of 84.7% from ¥405.6 million in the prior-year period.

The normalized profit margin dropped to 1.7% from 10.1% in the year-earlier period.

Total revenue fell 8.1% year over year to ¥3.69 billion from ¥4.01 billion, and total operating expenses climbed 6.9% year over year to ¥3.58 billion from ¥3.34 billion.

Reported net income declined 65.9% year over year to ¥136.0 million, or ¥34.57 per share, from ¥399.0 million, or ¥101.43 per share.

As of Feb. 16, US$1 was equivalent to ¥118.46.